Ethanol promotes chemically induced oral cancer in mice through activation of the 5-lipoxygenase pathway of arachidonic acid metabolism

Cancer Prevention Research

Volumn 4, Issue 11, 2011, Pages 1863-1872

  Guo, Yizhu ^a,b,c   Wang, Xin ^a,d   Zhang, Xinyan ^a   Sun, Zheng ^a   Chen, Xiaoxin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c Department of Stomatology   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ALCOHOL; ARACHIDONATE 5 LIPOXYGENASE; CD31 ANTIGEN; CYCLOOXYGENASE 2; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; WATER;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER INHIBITION; CANCER MODEL; CANCER TISSUE; CARCINOMA CELL; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; MAST CELL; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; SQUAMOUS CELL CARCINOMA;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BLOTTING, WESTERN; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; COCARCINOGENESIS; CYCLOOXYGENASE 2; DRINKING WATER; EPOXIDE HYDROLASES; ETHANOL; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOTRIENE B4; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOUTH NEOPLASMS; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS;

EID: 81555210874     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0206     Document Type: Article

References (48)

1. Magrath I, Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 1993;85:862-74. (Pubitemid 23157126)
2. Mackenzie J, Ah-See K, Thakker N, Sloan P, Maran AG, Birch J, et al. Increasing incidence of oral cancer amongst young persons: what is the etiology? Oral Oncol 2000;36:387-9. (Pubitemid 30427261)
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
4. Levi F, Randimbison L, Te VC, Franceschi S, La Veccchia C. Trends in cancer survival in Vaud, Switzerland. Eur J Cancer 1992;28: 1490-5.
5. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. 2010. Available from: http://seercancergov/csr/1975-2007/
6. Vecchia CL, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997;33: 302-12. (Pubitemid 28129230)
7. Johnson N. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001;65:328-39.
8. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85:1700-5.
9. Huang WY, Winn DM, Brown LM, Gridley G, Bravo-Otero E, Diehl SR, et al. Alcohol concentration and risk of oral cancer in Puerto Rico. Am J Epidemiol 2003;157:881-7. (Pubitemid 36555047)
10. Maserejian NN, Joshipura KJ, Rosner BA, Giovannucci E, Zavras AI. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 2006;15: 774-81.
11. Maier H, Weidauer H, Zoller J, Seitz HK, Flentje M, Mall G, et al. Effect of chronic alcohol consumption on the morphology of the oral mucosa. Alcohol Clin Exp Res 1994;18:387-91. (Pubitemid 24138335)
12. Soffritti M, Belpoggi F, Cevolani D, Guarino M, Padovani M, Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann N Y Acad Sci 2002; 982:46-69. (Pubitemid 36127071)
13. Henefer EP. Ethanol, 30 per cent, and hamster pouch carcinogenesis. J Dent Res 1966;45:838-44.
14. Elzay RP. Effect of alcohol and cigarette smoke as promoting agents in hamster pouch carcinogenesis. J Dent Res 1969;48:1200-5.
15. Elzay RP. Local effect of alcohol in combination with DMBA on hamster cheek pouch. J Dent Res 1966;45:1788-95.
16. Nachiappan V, Mufti SI, Eskelson CD. Ethanol-mediated promotion of oral carcinogenesis in hamsters: association with lipid peroxidation. Nutr Cancer 1993;20:293-302. (Pubitemid 23350030)
17. Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 2004;10:301-13. (Pubitemid 38114193)
18. Li N, Sood S, Wang S, Fang M, Wang P, Sun Z, et al. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clin Cancer Res 2005;11:2089-96. (Pubitemid 40471876)
19. Sun Z, Sood S, Li N, Ramji D, Yang P, Newman RA, et al. Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12- dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis 2006;27:1902-8. (Pubitemid 44288671)
20. Sun Z, Guan X, Li N, Liu X, Chen X. Chemoprevention of oral cancer in animal models and human patients with ZengShengPing, a mixture of medicinal herbs. Oral Oncol 2010;45:105-10.
21. Luo M, Jones SM, Peters-Golden M, Brock TG. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc Natl Acad Sci U S A 2003;100:12165-70. (Pubitemid 37271532)
22. Siegmund S, Haas S, Schneider A, Singer MV. Animal models in gastrointestinal alcohol research-a short appraisal of the different models and their results. Best Pract Res Clin Gastroenterol 2003; 17:519-42.
23. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. (Pubitemid 47106631)
24. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. Alcohol Clin Exp Res 1997;21:1199-203. (Pubitemid 27446886)
25. Bode C, Maute G, Bode JC. Prostaglandin E2 and prostaglandin F2 alpha biosynthesis in human gastric mucosa: effect of chronic alcohol misuse. Gut 1996;39:348-52. (Pubitemid 26338519)
26. Boughton-Smith NK, Whittle BJ. Inhibition by 16,16-dimethyl PGE2 of ethanol-induced gastric mucosal damage and leukotriene B4 and C4 formation. Prostaglandins 1988;35:945-57.
27. Gyomber E, Vattay P, Szabo S, Rainsford KD. Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat. J Gastroenterol Hepatol 1996;11:922-7. (Pubitemid 26338278)
28. Hattori Y, Ohno T, Ae T, Saeki T, Arai K, Mizuguchi S, et al. Gastric mucosal protection against ethanol by EP2 and EP4 signaling through the inhibition of leukotriene C4 production. Am J Physiol Gastrointest Liver Physiol 2008;294:G80-7.
29. Funk CD, Chen XS, Johnson EN, Zhao L. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat 2002;68-69:303-12. (Pubitemid 35247403)
30. Chen X, Sood S, Yang CS, Li N, Sun Z. Five-lipoxygenase pathway of arachidonic acid metabolism in carcinogenesis and cancer chemoprevention. Curr Cancer Drug Targets 2006;6: 613-22. (Pubitemid 44691003)
31. Melstrom LG, Bentrem DJ, Salabat MR, Kennedy TJ, Ding XZ, Strouch M, et al. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 2008;14:6525-30.
32. Martinez-Clemente M, Ferre N, Gonzalez-Periz A, Lopez-Parra M, Horrillo R, Titos E, et al. 5-Lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice. Hepatology 2010;51:817-27.
33. Chen Y, Hu Y, Zhang H, Peng C, Li S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 2009;41:783-92.
34. McCormick DL, Phillips JM, Horn TL, Johnson WD, Steele VE, Lubet RA. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors. Cancer Prev Res 2010;3:73-81.
35. Matthews JB, Mason GI, Scully CM, Prime SS. In situ characterisation of the oral mucosal inflammatory cell response of rats induced by 4- nitroquinoline-N-oxide. Carcinogenesis 1986;7:783-8. (Pubitemid 17126066)
36. Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, Hannun YA, et al. A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer Prev Res 2011;4:454-62.
37. Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, Thomas SM, et al. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prev Res 2011;4:230-7.
38. Czerninski R, Amornphimoltham P, Patel V, Molinolo AA, Gutkind JS. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev Res 2009;2:27-36.
39. Hasina R, Martin LE, Kasza K, Jones CL, Jalil A, Lingen MW. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prev Res 2009;2: 385-93.
40. Tang XH, Albert M, Scognamiglio T, Gudas LJ. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Cancer Prev Res 2009;2:1100-10.
41. Fong LY, Jiang Y, Riley M, Liu X, Smalley KJ, Guttridge DC, et al. Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2. Int J Cancer 2008;122:978-89. (Pubitemid 351213994)
42. Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, et al. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res 2009;2:322-9.
43. Romano M, Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 2003;17:1986-95. (Pubitemid 37392443)
44. Fan XM, Tu SP, Lam SK, Wang WP, Wu J, Wong WM, et al. Fivelipoxygenase- activating protein inhibitor MK-886 induces apoptosis in gastric cancer through upregulation of p27kip1 and bax. J Gastroenterol Hepatol 2004;19:31-7. (Pubitemid 38130604)
45. Boyce JA. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 2007;217: 168-85. (Pubitemid 46718145)
46. Aromando RF, Perez MA, Heber EM, Trivillin VA, Tomasi VH, Schwint AE, et al. Potential role of mast cells in hamster cheek pouch carcinogenesis. Oral Oncol 2008;44:1080-7.
47. Cheon EC, Khazaie K, Khan MW, Strouch MJ, Krantz SB, Phillips J, et al.Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APC{Delta}468 mice. Cancer Res 2011;71:1627-36.
48. Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, Brash AR, et al. The structure of human 5-lipoxygenase. Science 2011;331: 217-9.